drugset / Trial / NCT06652971

A Clinical Trial to Evaluate the Food Effect of CKD-379

NCT06652971

Phase 1 Completed 30 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

A clinical trial to evaluate the food effect of CKD-379

Timeline

Start
2024-11-05
Primary completion
2024-12-04
Completion
2024-12-17

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-379 Unknown Oral